Sanofi’s Dupixent rolls on, but US flu shots took backseat to COVID-19 boosters in the fourth quarter

Sanofi’s Dupixent rolls on, but US flu shots took backseat to COVID-19 boosters in the fourth quarter
fkansteiner
Fri, 02/04/2022 – 09:47